Avantax Advisory Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$285K Sell
5,369
-1,219
-19% -$61.9K ﹤0.01% 1951
2025
Q1
$285K Buy
6,588
+1,259
+24% +$63.8K ﹤0.01% 1867
2024
Q4
$299K Sell
5,329
-978
-16% -$60.9K ﹤0.01% 1780
2024
Q3
$430K Sell
6,307
-520
-8% -$29.3K ﹤0.01% 1515
2024
Q2
$288K Buy
6,827
+3,735
+121% +$206K ﹤0.01% 1726
2024
Q1
$214K Buy
3,092
+9
+0.3% +$569 ﹤0.01% 1510
2023
Q4
$228K Sell
3,083
-104
-3% -$6.82K ﹤0.01% 1399
2023
Q3
$217K Sell
3,187
-634
-17% -$53.8K ﹤0.01% 1383
2023
Q2
$359K Sell
3,821
-370
-9% -$28.9K ﹤0.01% 1088
2023
Q1
$284K Buy
+4,191
New +$269K ﹤0.01% 1179
2022
Q1
Sell
-2,628
Closed -$205K 1308
2021
Q4
$205K Sell
2,628
-235
-8% -$20.7K ﹤0.01% 1161
2021
Q3
$275K Sell
2,863
-113
-4% -$11.9K ﹤0.01% 964
2021
Q2
$369K Buy
2,976
+497
+20% +$59.3K 0.01% 815
2021
Q1
$327K Sell
2,479
-43
-2% -$5.89K 0.01% 773
2020
Q4
$334K Buy
2,522
+241
+11% +$29.1K 0.01% 685
2020
Q3
$233K Buy
+2,281
New +$197K ﹤0.01% 1149

Other funds holding EXAS

Avantax Advisory Services's EXAS Position: Q2 2025 in Review

Avantax Advisory Services reduced its Exact Sciences (EXAS) stake by 19% in Q2 2025, selling an estimated $61.9K and leaving 5,369 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

Avantax Advisory Services first reported a position in EXAS in Q3 2020 and has held it in 16 quarters since. The position peaked at $430K in Q3 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Avantax Advisory Services held 5,369 shares of Exact Sciences worth $285K as of Q2 2025.
  • Avantax Advisory Services sold 1,219 Exact Sciences shares in Q2 2025, an estimated $61.9K.
  • Exact Sciences made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1951 holding.
  • Avantax Advisory Services first reported a position in Exact Sciences in Q3 2020 and has held it in 16 quarters since.
  • Avantax Advisory Services's Exact Sciences position peaked at $430K in Q3 2024.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.